Skip to main content
. Author manuscript; available in PMC: 2017 Mar 8.
Published in final edited form as: Vaccine. 2016 Feb 6;34(11):1363–1369. doi: 10.1016/j.vaccine.2016.01.051

Table 2.

GMT and mean fold increase (MFI) of HI and MN titers before and after a single dose of influenza vaccine.

Influenza subtype HI
MN
Heroin users (n = 10) Methadone users (n = 11) Non user controls (n = 20) p value Heroin users (n = 10) Methadone users (n = 11) Non user controls (n = 20) p value
A/California/7/2009 (H1N1)
 Prevaccine 7.6 (3.9, 14.8) 16.6 (8.0, 34.2) 10.0 (6.2, 16.2) 0.16 19.9 (10.2, 38.8) 43.04 (20.7, 98.2) 20.1 (13.0, 30.8) 0.14
 Postvaccine 278.6 (93.5, 829.7) 205.9 (72.3, 586.5) 149.3 (80.9, 275.5) 0.18 416.6 (169.3, 1025.2) 643.8 (225.6, 1837.8) 283.2 (117.4, 683.6) 0.57
 MFI 21.9 (9.4, 51.1) 8.2 (4.3, 15.7) 12.2 (7.3, 20.4) 0.17 8.4 (5.4, 13.2) 6.8 (3.7, 12.6) 7.2 (5.0, 10.4) 0.67
A/Victoria/210/2009 (H3N2)
 Prevaccine 20.0 (7.9, 50.9) 24.2 (7.7, 75.7) 16.8 (10.1, 28.2) 0.94 66.0 (21.8, 199.9) 65.4 (21.2, 202) 46.3 (21.5, 99.9) 0.72
 Postvaccine 172.8 (79.7, 374.8) 124.4 (55.1, 280.6) 121.3 (83.7, 175.7) 0.52 521.9 (233, 1128) 513.8 (176.4, 1496.3) 353.2 (195, 627) 0.25
 MFI 7.3 (3.4, 15.6) 6.1 (3.6, 10.5) 7.0 (4.9, 10.0) 0.88 5.0 (3.3, 7.7) 5.3 (3.3, 8.5) 5.6 (4.3, 7.3) 0.96
B/Brisbane/60/2008
 Prevaccine 5.7 (4.7, 7.1) 12.1 (5.9, 24.9) 13.2 (8.1, 21.5) 0.06 14.1 (9.3, 21.6) 20.2 (10.5, 39.1) 19.4 (10.3, 36.7) 0.44
 Postvaccine 26.4 (11.7, 59.7) 29.2 (12.9, 66.1) 47.6 (31.3, 72.4) 0.36 31.9 (15.9, 64.2) 36.6 (16.4, 81.6) 54.4 (31.7, 93.2) 0.42
 MFI 6.8 (4.0, 11.8) 4.2 (2.9, 6.1) 5.5 (3.9, 7.8) 0.33 3.8 (2.8, 5.1) 3.5 (2.5, 5.1) 4.3 (3.5, 5.4) 0.36

Data are geometric means (95% confidence interval), unless defined otherwise.